Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome

Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome

Background and Aim: High lipoprotein(a) [Lp(a)] is a well-established cardiovascular (CV) risk factor, but the effect of mildly elevated Lp(a) on CV health is largely unknown. Our aim was to evaluate if Lp(a) is associated with the severity of carotid atherosclerosis (CA) in the specific subset of m...

Full description

Bibliographic Details
Main Authors: Anna Laura Cremonini, Andrea Pasta, Federico Carbone, Luca Visconti, Matteo Casula, Edoardo Elia, Aldo Bonaventura, Luca Liberale, Maria Bertolotto, Nathan Artom, Silvia Minetti, Paola Contini, Daniela Verzola, Roberto Pontremoli, Francesca Viazzi, Giorgio Luciano Viviani, Stefano Bertolini, Aldo Pende, Fabrizio Montecucco, Livia Pisciotta
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Molecular Biosciences
Subjects:
lipoprotein (a)
atherosclerosis
metabolic syndrome
cardiovascular disease
ASCVD
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.854624/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.854624/full

Similar Items